Related Experiment Video
Updated: Jan 29, 2026
09:25
Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain
Published on: May 21, 2019
7.2K
Ubiquitin-Proteasome System in Neurodegenerative Disorders
Geeta Rao1, Brandon Croft1, Chengwen Teng1
1Department of Pharmaceutical Sciences, University of Oklahoma Health Science Center, Oklahoma City, OK, USA.
Journal of Drug Metabolism & Toxicology
|February 15, 2019
Summary
Cellular proteostasis relies on the ubiquitin-proteasome system (UPS). Enhancing UPS function may treat neurodegenerative diseases by clearing protein aggregates, unlike cancer therapies.
Area of Science:
- Molecular Biology
- Neuroscience
- Cell Biology
Background:
- Cellular proteostasis maintains protein health via the ubiquitin-proteasome system (UPS).
- Dysfunctional UPS leads to protein aggregate buildup, implicated in neurodegenerative diseases like Alzheimer's and Parkinson's.
- Current cancer therapies inhibit the proteasome, but neurodegenerative diseases may benefit from its activation.
Purpose of the Study:
- To review the role of the proteasome in neurodegenerative disorders.
- To explore the therapeutic potential of modulating proteasome function in these diseases.
Main Methods:
- Literature review of proteasome function in neurodegeneration.
- Analysis of studies on protein aggregation and clearance mechanisms.
- Synthesis of current research on proteasomal modulation strategies.
Main Results:
- The UPS is crucial for degrading misfolded proteins, preventing toxic aggregate formation.
- Impaired UPS function is a key factor in the pathogenesis of neurodegenerative conditions.
- Activating the proteasome presents a potential therapeutic avenue for neurodegenerative diseases.
Conclusions:
- Proteasome dysfunction contributes significantly to neurodegeneration.
- Targeting the proteasome for activation offers a promising therapeutic strategy.
- Further research into proteasomal modulation is warranted for treating neurodegenerative disorders.
Keywords:
Brain pathologiesNeurodegenerative disordersProteasome modulatorsProteostasisUbiquitin-proteasome systemMore Related Videos
06:30Quantitative Analysis of Climbing Defects in a Drosophila Model of Neurodegenerative Disorders
Published on: June 13, 2015
19.8K
07:05Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
Published on: September 27, 2024
975
Related Concept Videos
02:18The Proteasome
10.2K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.2K
01:13The Proteasome
1.7K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.7K
02:18The Proteasome
4.6K
4.6K
01:17The Proteasome Structure
1.7K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
1.7K
02:18Intrinsically Disordered Proteins
19.4K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.4K
01:29Bone Disorders
5.3K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.3K